Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Feb 11;11(2):284.
doi: 10.3390/diagnostics11020284.

Serum microRNA Levels in Diabetes Mellitus

Affiliations

Serum microRNA Levels in Diabetes Mellitus

Rodolfo Mastropasqua et al. Diagnostics (Basel). .

Abstract

The aim of our study is to evaluate the serum circulating levels of some miRNA, such as hsa-let-7b-5p, hsa-let-7a-5p, hsa-miR-320b, hsa-miR-23a-3p, hsa-miR-27a-3p, hsa-miR-15a-5p, and hsa-miR-495-3, in diabetic patients without diabetic retinopathy (DR), diabetic patients with DR, and, healthy subjects in order to find reliable and reproducible biomarkers for DR. A total of 45 subjects underwent serum sampling for miRNAs evaluation and a complete ophthalmologic examination, including microperimetry and widefield swept source optical coherence tomography angiography (OCTA). Total circulating RNA was isolated from patients using the miRNeasy Serum/Plasma Kit. Serum miRNA expression levels were significantly different in the three groups. In detail, circulating hsa-miR-15a-5p levels were significantly reduced in both diabetic patients without DR and diabetic patients with DR (p = 0.027). Serum hsa-miR-495-3p was lower in diabetic patients with DR and diabetic patients without DR (p = 0.049). Hsa-miR-23a-3p serum expression levels were significantly lower in diabetic patients with DR and diabetic patients without DR (p = 0.013). Significant associations of miRNAs with anatomical/perfusion parameters and functional parameters were observed in the diabetic groups. We find evidence of damage in progression biomarkers in DR that are evidently early in patients with diabetes without DR. Serum miRNAs levels are considered to have strong potential as a novel biomarker for the early detection of DR in subjects suffering from diabetes and could represent noninvasive target therapies to block the progression of the disease at the early stages.

Keywords: diabetes mellitus; diabetic retinopathy; serum microRNA.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Comparison of OCT (first line), widefield OCTA (SCP, second line; DCP, third line; CC, third line), and microperimetry (fourth line) among the three groups (healthy (A); DM without DR (B); DM with NPDR, (C)). Abbreviations: OCT, optical coherence tomography; OCTA, optical coherence tomography angiography; SCP, superficial capillary plexus; DCP, deep capillary plexus; CC, choriocapillaries; DM, diabetes mellitus; DR, diabetic retinopathy; NPDR, nonproliferative diabetic retinopathy.
Figure 2
Figure 2
Radar plot for median values of miRNAs.

References

    1. Sivaprasad S., Pearce E. The unmet need for better risk stratification of non-proliferative diabetic retinopathy. Diabet. Med. 2019;36:424–433. doi: 10.1111/dme.13868. - DOI - PMC - PubMed
    1. Simó-Servat O., Hernández C., Simó R. Diabetic Retinopathy in the Context of Patients with Diabetes. Ophthalmic. Res. 2019;62:211–217. doi: 10.1159/000499541. - DOI - PubMed
    1. Cheung N., Mitchell P., Wong T.Y. Diabetic retinopathy. Lancet. 2010;376:124–136. doi: 10.1016/S0140-6736(09)62124-3. - DOI - PubMed
    1. Zhang Q., Rezaei K.A., Saraf S.S., Chu Z., Wang F., Wang R.K. Ultra-wide optical coherence tomography angiography in diabetic retinopathy. Quant. Imaging Med. Surg. 2018;8:743–753. doi: 10.21037/qims.2018.09.02. - DOI - PMC - PubMed
    1. Mastropasqua R., D’Aloisio R., Di Antonio L., Erroi E., Borrelli E., Evangelista F., D’Onofrio G., Di Nicola M., Di Martino G., Toto L. Widefield optical coherence tomography angiography in diabetic retinopathy. Acta Diabetol. 2019;56:1293–1303. doi: 10.1007/s00592-019-01410-w. - DOI - PubMed

LinkOut - more resources